MRI1
Methylthioribose-1-phosphate isomerase
Also known as: MGC3207, MRDI, mtnA, MTNA_HUMAN, Ypr118w
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BV20
- Gene
- MRI1
- Ensembl
- ENSG00000037757
- Chromosome
- 19
- Canonical length
- 369 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Cytosol
OverviewNCBI Gene
This enzyme functions in the methionine salvage pathway by catalyzing the interconversion of methylthioribose-1-phosphate and methythioribulose-1-phosphate. Elevated expression of the encoded protein is associated with metastatic melanoma and this protein promotes melanoma cell invasion independent of its enzymatic activity. Mutations in this gene may be associated with vanishing white matter disease (VMWD). [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
369 residues, UniProt reviewed canonical sequence.
>Q9BV20|MRI1
1 MTLEAIRYSR GSLQILDQLL LPKQSRYEAV GSVHQAWEAI RAMKVRGAPA IALVGCLSLA
61 VELQAGAGGP GLAALVAFVR DKLSFLVTAR PTAVNMARAA RDLADVAARE AEREGATEEA
121 VRERVICCTE DMLEKDLRDN RSIGDLGARH LLERVAPSGG KVTVLTHCNT GALATAGYGT
181 ALGVIRSLHS LGRLEHAFCT ETRPYNQGAR LTAFELVYEQ IPATLITDSM VAAAMAHRGV
241 SAVVVGADRV VANGDTANKV GTYQLAIVAK HHGIPFYVAA PSSSCDLRLE TGKEIIIEER
301 PGQELTDVNG VRIAAPGIGV WNPAFDVTPH DLITGGIITE LGVFAPEELR TALTTTISSR
361 DGTLDGPQMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MRI1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- skin: 21 nTPM
- ovary: 20 nTPM
- cervix: 20 nTPM
- cerebellum: 19 nTPM
- liver: 19 nTPM
- spleen: 19 nTPM
Single-cell type
- bergmann glia: 42 nCPM
- other brain neurons: 42 nCPM
- brain excitatory neurons: 40 nCPM
- brain inhibitory neurons: 39 nCPM
- adipocytes: 38 nCPM
- fibro-adipogenic progenitors: 36 nCPM
Immune cell
- basophil: 3.3 nTPM
- plasmacytoid DC: 2.7 nTPM
- memory CD8 T-cell: 2.1 nTPM
- classical monocyte: 1.8 nTPM
- MAIT T-cell: 1.8 nTPM
- NK-cell: 1.8 nTPM
Brain region
- white matter: 23 nTPM
- cerebellum: 20 nTPM
- medulla oblongata: 19 nTPM
- pons: 19 nTPM
- cerebral cortex: 19 nTPM
- thalamus: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- identical protein binding
- S-methyl-5-thioribose-1-phosphate isomerase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Initiation factor 2B-related
- NagB/RpiA transferase-like
- Initiation factor 2B-like, C-terminal
- Initiation factor 2 subunit family
- Methylthioribose-1-phosphate isomerase
- Initiation factor 2B alpha/beta/delta
- Methylthioribose-1-phosphate isomerase, N-terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MRI1 as an antibody target. Whether an autoantibody or antibody against MRI1 could matter depends on whether native MRI1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MRI1 is annotated at the cell surface, where native MRI1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MRI1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...